ad image

Q42021

1 / 2
Cloud Control: Maintaining Compliance as Regulated Apps Move Off Premise
Cloud Regulatory Compliance

Cloud Control: Maintaining Compliance as Regulated Apps Move Off Premise

Thierry Dietrich, Ph.D.

PAO-07-022-CL-08Jul 19, 2022
Expanding the Cell and Gene Therapy Ecosystem in Philadelphia
Column: Regional

Expanding the Cell and Gene Therapy Ecosystem in Philadelphia

David Alvaro, Ph.D.

Pharma's Almanac

PAO-12-21-CL-05Mar 23, 2022
Samsung Biologics
Financial Results

Samsung Biologics Reports Fourth Quarter & Fiscal Year 2021 Financial Results

Samsung Biologics

PR-M01-22-16Jan 24, 2022
Q: What do you see as the key innovations or technologies that will make personalized/precision medicine a reality?
Personalized and Precision Medicine

Q: What do you see as the key innovations or technologies that will make personalized/precision medicine a reality?

Pharma's Almanac

PAO-12-21-RT-01Jan 07, 2022
Q: For what therapeutic area do you think we will see the greatest progress in the coming years?
Therapeutic Progress

Q: For what therapeutic area do you think we will see the greatest progress in the coming years?

Pharma's Almanac

PAO-12-21-RT-02Jan 07, 2022
2021 Roundup: The Year of Cell and Gene Therapy

2021 Roundup: The Year of Cell and Gene Therapy

David Alvaro, Ph.D.

Pharma's Almanac

PA734Dec 20, 2021
Cell and Gene Therapies’ Evolving Temperature-Controlled Requirements Call for Specialized Logistics Solutions
Cell and Gene Therapy

Cell and Gene Therapies’ Evolving Temperature-Controlled Requirements Call for Specialized Logistics Solutions

Yourway

PAO-11-21-CL-11Dec 14, 2021
Leveraging True Expertise and Flexibility for Lipid Nanoparticle Clinical Manufacturing
Lipid Nanoparticles

Leveraging True Expertise and Flexibility for Lipid Nanoparticle Clinical Manufacturing

Cole Byvelds, P.Eng.; Kristina Parrant

Evonik

PA656Dec 14, 2021
A CDMO Dedicated to Supporting Small-Volume, Small-Molecule Parenteral Projects
Parenteral Drugs

A CDMO Dedicated to Supporting Small-Volume, Small-Molecule Parenteral Projects

Marga Viñes; Oriol Prat; Oriol Argemi

Grifols

PAO-12-21-CL-02Dec 13, 2021
Growing Life Science and Biotech in Montana
Biotechnology

Growing Life Science and Biotech in Montana

Sharon Peterson

Montana Bioscience Alliance

PAO-12-21-CL-03Dec 08, 2021
A Small Biotech with Two Complex Bispecific Antibody Candidates Benefits from Lonza’s Blend of Expertise and Flexibility
Bispecific Antibodies

A Small Biotech with Two Complex Bispecific Antibody Candidates Benefits from Lonza’s Blend of Expertise and Flexibility

Craig Parker

PAO-12-21-CL-01Dec 03, 2021
Boosting Cell Densities and Productivity with Tailored Media in Seed Train
Biomanufacturing

Boosting Cell Densities and Productivity with Tailored Media in Seed Train

Melanie Brandl, Ph.D.

MilliporeSigma

PAO-11-21-CL-17Dec 03, 2021
Supporting Innovative Biotechs to Bring Cell and Gene Therapies to Market
Cell and Gene Therapy

Supporting Innovative Biotechs to Bring Cell and Gene Therapies to Market

Philip Gialenios

Kineticos Life Sciences

PAO-11-21-CL-15Dec 01, 2021
An Evolving Biologics Landscape and Driving Innovation and Opportunity
Biologics

An Evolving Biologics Landscape and Driving Innovation and Opportunity

Tim Roberts

PCI Pharma Services

PAO-11-21-CL-16Nov 30, 2021
Integrating a Fragmented mRNA Supply Chain
mRNA Manufacturing

Integrating a Fragmented mRNA Supply Chain

Dave Stevens

Arranta Bio

PAO-11-21-CL-04Nov 22, 2021
Exploring Innovation and the Vast Potential of Transdermal Patch Drug Delivery
Transdermals

Exploring Innovation and the Vast Potential of Transdermal Patch Drug Delivery

Maria Gordon; Beau Garrett

Nice Insight

PAO-11-21-CL-13Nov 22, 2021
Evaluating Single-Use Technologies for Biomanufacturing
Single-Use Technologies

Evaluating Single-Use Technologies for Biomanufacturing

Chris Barnett

Scorpius BioManufacturing

PAO-11-21-CL-08Nov 22, 2021
Leveraging Partnerships and a Unique History to Address Supply Chain and Capacity Challenges in Gene Therapy Manufacturing
Gene Therapy Manufacturing

Leveraging Partnerships and a Unique History to Address Supply Chain and Capacity Challenges in Gene Therapy Manufacturing

Wade Macedone; Adam Lauber

Andelyn Biosciences

PAO-11-21-CL-14Nov 18, 2021
Accelerating Biologics Development with High-Quality Protein Stabilization Excipients
Formulation

Accelerating Biologics Development with High-Quality Protein Stabilization Excipients

Balu Guduri; Nelli Erwin, Ph.D.

MilliporeSigma

PAO-11-21-CL-12Nov 18, 2021
Bringing 3D Organoid Models Into a High-Throughput Environment
Organoids

Bringing 3D Organoid Models Into a High-Throughput Environment

Elizabeth Abraham, Ph.D.; Dennis Plenker, Ph.D.; Hervé Tiriac, Ph.D.

Corning Life Sciences

PAO-11-21-CL-09Nov 11, 2021
1 / 2